SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending following a positive update that raised its year-end AI cloud revenue targets and revealed $2.8 billion in new multi-year contracts with prominent AI developers. The community is actively discussing the impact of these customer prepayments on reducing dilution concerns, while traders debate whether the news signals a long-term bottom or provides a temporary exit point for short-term sentiment.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors respond to an Nvidia filing that confirmed a 9.3% passive stake in the company, which the community sees as a major vote of confidence in its AI cloud infrastructure. While some are debating whether this is new information or a previously disclosed warrant conversion, shareholders are actively discussing potential squeeze opportunities, analyst price target upgrades, and long-term potential as a key player in the hyperscaler ecosystem.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing intense volatility as the semiconductor sector battles a sharp sell-off triggered by concerns over AI capital expenditure sustainability and broader geopolitical tensions. Community sentiment is deeply divided, with many traders debating whether this is a structural market correction or a significant buying opportunity for those looking to capitalize on the sector's long-term growth potential.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is capturing significant market attention following the unveiling of "Thunder," an autonomous hybrid-electric VTOL platform developed alongside Anduril Industries for defense and commercial applications. While the community is actively debating the company's timeline for commercialization and its pivot toward defense contracts, bullish investors are highlighting the firm's liquidity and strategic partnerships as key indicators of long-term potential.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending as investors debate its long-term positioning within the U.S. quantum ecosystem, with community sentiment divided between those seeing a generational buying opportunity and skeptics questioning its revenue maturity compared to peers. Discussion is heavily focused on the company's strategic government initiatives and the potential impact of future commercialization milestones versus competitors like Infleqtion.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as investors react to the completion of the TopBuild acquisition, which has introduced significant selling pressure from converted shareholders and concerns regarding dilution. While community sentiment is deeply divided, many remain bullish on the long-term potential of the CEO's growth strategy and are viewing the current price weakness as a critical accumulation opportunity despite ongoing market volatility.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Investors are actively debating whether the record-breaking semiconductor rally is reaching a turning point, with strong options activity indicating institutional hedging alongside concerns about the sustainability of massive AI-driven capital expenditures. While community sentiment remains split between 'buying the dip' to capitalize on long-term infrastructure demand and fears of an overheated sector facing a deeper corrective retracement, price action is being closely monitored as key technical support levels are tested.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is seeing volatile trading as investors digest a new hyperscaler partnership with Microsoft for its Helios AI rack-scale systems while balancing broader sector rotation and AI-related spending concerns. The community remains divided, with active debates centered on whether recent price swings represent a buying opportunity ahead of upcoming earnings and an AI event, or a structural breakdown in high-beta tech momentum.

General Fusion Group Ltd. engages in the fusion industry, developing practical magnetized target fusion technology that is designed to address the key barriers to commercializing fusion. The company is headquartered in Richmond, Canada.

General Fusion Group Ltd.

General Fusion is trending following its recent Nasdaq debut under the ticker GFUZ, as investors debate its long-term viability and compare it against other fusion technology plays in the sector. Community discourse remains divided between those optimistic about the company's patented Magnetized Target Fusion technology and others expressing skepticism regarding commercial timelines and the impact of future share dilution.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors debate the sustainability of its AI foundry strategy and long-term manufacturing roadmap ahead of upcoming earnings. The community remains deeply divided, with bulls pointing to the stock's role in domestic chip infrastructure and potential valuation upside, while bears highlight significant short-term volatility and concerns over broader semiconductor sector momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tamara A Favorito Expands Holdings With $51K Zevra Therapeutics Stock Options Acquisition

A notable acquisition unfolded on June 18, as Favorito, Director at Zevra Therapeutics (NASDAQ:ZVRA), reported the acquisition of stock options for 30,000 shares in an SEC filing.
What Happened: A Form 4 filing from theread more...

Corey M. Watton Seizes Opportunity: Acquires $51K Worth Of Zevra Therapeutics Stock Options

In a recent SEC filing, it was disclosed that Corey M. Watton, Board Member at Zevra Therapeutics (NASDAQ:ZVRA), made a noteworthy acquisition of company stock options on June 18,.
What Happened: A Form 4 filing fromread more...

A Noteworthy Decision By Thomas Anderson As Acquires $51K In Zevra Therapeutics Stock Options

In a new SEC filing on June 18, it was unveiled that Anderson, Director at Zevra Therapeutics (NASDAQ:ZVRA), acquired stock options for 30,000 shares.
What Happened: Uncovered in a Form 4 filing on Thursday with theread more...

Alicia Secor Takes A Bullish Stance, Acquiring $51K Worth Of Zevra Therapeutics Stock Options

A noteworthy insider acquisition was disclosed on June 18, as Secor, Board Member at Zevra Therapeutics (NASDAQ:ZVRA), reported the acquisition of stock options for 30,000 shares.
What Happened: Uncovered in a Form 4read more...

Douglas W Calder Makes Strategic Play: Invests $51K In Zevra Therapeutics Stock Options

In a new SEC filing on June 18, it was unveiled that Calder, Board Member at Zevra Therapeutics (NASDAQ:ZVRA), acquired stock options for 30,000 shares.
What Happened: Calder, Board Member at Zevra Therapeutics,read more...

Big News: Alvin Shih Adds $51K In Zevra Therapeutics Stock Options Io Portfolio

In a new SEC filing on June 18, it was unveiled that Shih, Board Member at Zevra Therapeutics (NASDAQ:ZVRA), acquired stock options for 30,000 shares.
What Happened: In a recent Form 4 filing with the U.S. Securitiesread more...

ZVRA Stock Hits Its Highest Levels In Nearly 5 Years – What’s Driving This Sharp Rally Today?

Equity

Zevra Therapeutics shares saw a series of positive brokerage actions after the company asked the U.S. Food and Drug Administration to add a new patent for its Miplyffa drug to the Orange Book.

ZVRA Stock ‘Way Undervalued’? Analyst Sees 117% Upside After Patent Extends Exclusivity Till 2041 For Sole Approved Drug

Zevra said in a statement that it has asked the U.S. Food and Drug Administration to add its new patent for its drug MIPLYFFA to its official list.


Zevra Therapeutics (ZVRA) Q1 Earnings and Revenues Surpass Estimates

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of +184.36% and +15.51%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ocular Therapeutix (OCUL) Reports Q1 Loss, Misses Revenue Estimates

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -29.46% and -15.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$12.03
Prev Close	$12.77
Open	$12.80
Dividend Yield	0.00%
50-Day Moving Average	$12.26
Beta	0.82
Avg. Volume	1.96M
PE Ratio	5.59

52-Week High	$15.04
52-Week Low	$7.16
Market Capitalization	$754.9M
EPS (Annual)	$1.35
Price to Book	3.46
Revenue Per Employee	$1.75M

Feed

News

Sentiment

Earnings

Fundamentals

Info

ZVRAZevra Therapeutics Inc

Latest ZVRA News